- Company on track to fulfill rapidly increasing orders of syrup
- Precautionary step to meet anticipated widespread need for
TAMIFLU® Oral Solution among children and adult patients with difficulty
swallowing capsules
Humco Holding Group, Inc. today announced it has significantly increased
its October production of Humco® Cherry Syrup for use in the
emergency compounding by pharmacists of an oral suspension from Tamiflu®
capsules, intended for children and adults with difficulty swallowing
Tamiflu® capsules, or who require lower doses. The company
also said it is fulfilling in a timely manner significantly increased
orders placed in September.
A Tamiflu® Oral Suspension short supply situation could
develop this flu season based on current projections for influenza
incidence. Since November 2006, the FDA has permitted compounding of an
oral suspension from Tamiflu® capsules in emergency
situations, when FDA-approved, commercially manufactured Tamiflu®
Oral Suspension is not available. The FDA-approved Tamiflu® labeling for
such emergency usage references Cherry Syrup (Humco®), as one of the
only two syrups for emergency compounding. The Humco Cherry Syrup is the
only naturally sweetened syrup studied by the manufacturer of Tamiflu.
“We want to assure pharmacies and pharmacists of our capacity and
commitment to manufacture and ship, in a timely manner, Humco® Cherry
Syrup as circumstances dictate,” said Greg Pulido, CEO, Humco Holding
Group, Inc.
“We took extraordinarily high orders during September, and proactively
increased production to assure consistent, on-time deliveries,” Pulido
said. “Our aggressive October plans are geared to meet yet higher
anticipated demand, and to maintain on-time fulfillment.”
Pulido said Humco® Cherry Syrup is ready to ship immediately
through all major wholesalers to pharmacies, hospitals and community
health channels. “We are seeing many of the nation’s leading pharmacies
recommending a one-pint inventory per dispensing location, which we
agree is prudent,” he said.
The compounded suspension should not be used for convenience or when the
FDA-approved Tamiflu® Oral Suspension is commercially
available.Complete FDA guidelines and compounding instructions
are available at http://www.tamiflu.com/hcp/dosing/extprep.aspx
Humco® Cherry Syrup is manufactured by Texarkana, TX-based
Humco Holding Group, Inc., a developer and supplier of high-quality
medical products to pharmacists, retailers and direct to consumers. The
company is FDA-registered and meets FDA drug Current Good Manufacturing
Practices (GMPs) in its production of pharmaceuticals and pharmaceutical
ingredients such as Cherry Syrup. The company began operating in 1872 as
Hutchinson Medicine Company. Please visit www.humco.com
for more information.
Tamiflu® is a registered trademark of Roche Laboratories, Inc.